ViiV Healthcare – Innovation in HIV Care
Dr. Harmony Garges, Chief Medical Officer at ViiV Healthcare, a company dedicated to HIV medicines, research, and the people affected by HIV and AIDS discusses the current treatment landscape, key data from the 24th International AIDS Conference, HIV care as patients grow older, and where treatment may be headed next.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Treatment. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Treatment and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Treatment?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
For more information visit www.dovato.com and www.rukobia.com
Dr. Harmony Garges is the Chief Medical Officer at ViiV Healthcare – the only pharmaceutical company 100% dedicated to HIV – where she is responsible for Regulatory, Safety, and Medical Affairs across the company’s innovative pipeline and portfolio. Just like the company she works for, Harmony’s guiding mission is to ensure that no person living with HIV is left behind.
After obtaining her MD degree and completing her pediatrics residency at Duke University, Harmony pursued her interests in infectious diseases further with fellowships in Pediatric Infectious Diseases and Medical Microbiology at Duke, along with her MPH in Epidemiology from the University of North Carolina at Chapel Hill. Following her training, Harmony maintained an active clinical practice, seeing children and adolescents living with HIV and other infectious diseases at Duke from 2005 through 2018.
In 2005, Harmony first joined GSK’s HIV program in the Infectious Diseases group, working on global development programs as project physician leader. In this role she oversaw three successful New Drug and Marketing Authorization Applications and provided medical leadership and strategy for the development of various other anti-infectives including the first time in human trials of dolutegravir – the most prescribed HIV medicine in the world.
Subsequently, Harmony joined the Global Clinical Safety & Pharmacovigilance team at GSK, where she provided safety strategy and governance for several large global clinical development programs in Pharma. She then led a large, global team overseeing the safety aspects of GSK’s large Classic and Established Medicines portfolio. From there, she joined the Consumer Health business at GSK, where she spent three years as the Chief Medical Officer. She then joined ViiV Healthcare in 2016 and has held several roles in Global Medical Affairs before assuming her current role of Chief Medical Officer at the company in 2019.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
